Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
BNT-325 is under clinical development by BioNTech and currently in Phase II for Malignant Mesothelioma.
Coronavirus Disease 2019 (COVID-19) vaccine is under clinical development by China National Biotec Group and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.
Fosigotifator is under clinical development by Calico Life Sciences and currently in Phase II for Unspecified Central Nervous System Disorders.
A decrease in California’s sexually transmitted infections (STIs) followed early real-world adoption of doxycycline post-exposure prophylaxis (doxyPEP), suggesting real population-level benefits to this public health
Action by all stakeholders is required to protect authors and the public from predatory medical journals, an international group of prominent medical journal editors said
The first U.S. bird flu death was reported, a person in Louisiana who had been hospitalized with severe respiratory symptoms. Louisiana health officials announced the
Gabapentin didn’t appear to show a greater risk of falls after older adults started using it. The analysis compared new gabapentin users versus new duloxetine
Dialysis patients on denosumab (Prolia, Xgeva) had a lower risk for fracture but higher risk for a certain heart event, suggested an observational trial weighted